DE69716296D1 - Indan- oder dihydroindolderivate - Google Patents
Indan- oder dihydroindolderivateInfo
- Publication number
- DE69716296D1 DE69716296D1 DE69716296T DE69716296T DE69716296D1 DE 69716296 D1 DE69716296 D1 DE 69716296D1 DE 69716296 T DE69716296 T DE 69716296T DE 69716296 T DE69716296 T DE 69716296T DE 69716296 D1 DE69716296 D1 DE 69716296D1
- Authority
- DE
- Germany
- Prior art keywords
- dihydroindol
- indane
- derivatives
- dihydroindol derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 title 2
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C5/00—Details of stores covered by group G11C11/00
- G11C5/02—Disposition of storage elements, e.g. in the form of a matrix array
- G11C5/025—Geometric lay-out considerations of storage- and peripheral-blocks in a semiconductor storage device
-
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11C—STATIC STORES
- G11C7/00—Arrangements for writing information into, or reading information out from, a digital store
- G11C7/10—Input/output [I/O] data interface arrangements, e.g. I/O data control circuits, I/O data buffers
- G11C7/1048—Data bus control circuits, e.g. precharging, presetting, equalising
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK151496 | 1996-12-20 | ||
PCT/DK1997/000587 WO1998028293A1 (en) | 1996-12-20 | 1997-12-19 | Indane or dihydroindole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69716296D1 true DE69716296D1 (de) | 2002-11-14 |
DE69716296T2 DE69716296T2 (de) | 2003-09-11 |
Family
ID=8105631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69716296T Expired - Fee Related DE69716296T2 (de) | 1996-12-20 | 1997-12-19 | Indan- oder dihydroindolderivate |
Country Status (28)
Country | Link |
---|---|
US (3) | US6262087B1 (de) |
EP (1) | EP0946542B1 (de) |
JP (1) | JP3251300B2 (de) |
KR (1) | KR100432297B1 (de) |
CN (3) | CN1146556C (de) |
AR (1) | AR008545A1 (de) |
AT (1) | ATE225784T1 (de) |
AU (1) | AU731243B2 (de) |
BG (1) | BG63968B1 (de) |
BR (1) | BR9714039A (de) |
CZ (1) | CZ297416B6 (de) |
DE (1) | DE69716296T2 (de) |
DK (1) | DK0946542T3 (de) |
EA (1) | EA002158B1 (de) |
ES (1) | ES2185058T3 (de) |
HK (1) | HK1025775A1 (de) |
HU (1) | HUP0000079A3 (de) |
IL (1) | IL130133A (de) |
IS (1) | IS2018B (de) |
NO (2) | NO318978B1 (de) |
NZ (1) | NZ335973A (de) |
PL (1) | PL188418B1 (de) |
PT (1) | PT946542E (de) |
SK (1) | SK283678B6 (de) |
TR (1) | TR199901407T2 (de) |
UA (1) | UA66778C2 (de) |
WO (1) | WO1998028293A1 (de) |
ZA (1) | ZA9711376B (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9711376B (en) | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
TWI242011B (en) * | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
EP1068199B1 (de) * | 1998-04-08 | 2002-11-13 | Wyeth | N-aryloxyethyl-indolyl-alkylamine zur behandlung von depressionen |
US6150533A (en) * | 1998-04-08 | 2000-11-21 | American Home Products Corp. | N-aryloxyethyl-indoly-alkylamines for the treatment of depression |
TW528754B (en) * | 1998-04-29 | 2003-04-21 | Wyeth Corp | Indolyl derivatibes as serotonergic agents |
US6204274B1 (en) | 1998-04-29 | 2001-03-20 | American Home Products Corporation | Indolyl derivatives as serotonergic agents |
US6362371B1 (en) * | 1998-06-08 | 2002-03-26 | Advanced Medicine, Inc. | β2- adrenergic receptor agonists |
WO1999064044A1 (en) * | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
JP2002517437A (ja) * | 1998-06-08 | 2002-06-18 | アドバンスド メディスン インコーポレーテッド | 新規なナトリウムチャンネル薬剤および使用 |
ID27976A (id) | 1998-06-19 | 2001-05-03 | Lundbeck & Co As H | 4,5,6 dan 7-indol dan turunan-turunan indolin, pembuatan dan penggunaannya |
EP1089997A1 (de) * | 1998-06-19 | 2001-04-11 | H.Lundbeck A/S | 4,5,6 und 7-indol- und indolin-derivate, ihre herstellung und anwendung |
AR020773A1 (es) | 1998-10-16 | 2002-05-29 | Duphar Int Res | Compuesto derivados de 3-(tetrahidropiridin-4-il)indol, metodo para prepararlo, una composicion farmaceutica que los contiene, metodo para preparar dicha composicion y uso del compuesto |
UA70979C2 (uk) | 1998-12-23 | 2004-11-15 | Х. Луннбек А/С | Спосіб одержання 5-ціанофталіду |
NZ514671A (en) | 1999-04-14 | 2003-10-31 | H | Method for the preparation of citalopram |
AU4552200A (en) * | 1999-05-12 | 2000-12-05 | Solvay Pharmaceuticals B.V. | Method of treating psychotic disorders |
US6355644B1 (en) | 1999-06-14 | 2002-03-12 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
WO2000076967A1 (en) * | 1999-06-14 | 2000-12-21 | Neurogen Corporation | Benzylpiperazinyl-indolinylethanones |
US6642228B1 (en) * | 1999-06-24 | 2003-11-04 | Toray Industries, Inc. | α1b-adrenergic receptor antagonists |
DK1212320T3 (da) | 1999-08-23 | 2005-08-08 | Solvay Pharm Bv | Phenylpiperazinderivater som inhibitorer for genoptag af serotonin |
US6476051B2 (en) | 1999-12-17 | 2002-11-05 | Bristol-Myers Squibb Company | Antipsychotic heterocycle compounds |
PL358967A1 (en) * | 2000-06-14 | 2004-08-23 | H.Lundbeck A/S | Indole derivatives useful for the treatment of cns disorders |
DK1294710T3 (da) * | 2000-06-14 | 2005-10-03 | Lundbeck & Co As H | Indolderivater, der er egnede til behandlingen af CNS-lidelser |
AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
HUP0300786A2 (hu) * | 2000-06-29 | 2003-07-28 | H. Lundbeck A/S | A központi idegrendszer megbetegedéseinek kezelésére alkalmas indolszármazékok és ezeket tartalmazó gyógyszerkészítmények |
IL144816A (en) | 2000-08-18 | 2005-09-25 | Lundbeck & Co As H | Method for the preparation of citalopram |
AR032712A1 (es) | 2001-02-21 | 2003-11-19 | Solvay Pharm Bv | Un mesilato de derivados de fenilpiperazina y composiciones farmaceuticas que lo contienen |
AR033287A1 (es) * | 2001-05-09 | 2003-12-10 | Lundbeck & Co As H | Tratamiento del adhd |
AU2003215529A1 (en) * | 2002-03-27 | 2003-10-08 | H. Lundbeck A/S | The use of 3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-3,6-dihydro-2h-pyridin-4-yl)-6-chloro-1h-indole or its enantiomers for the treatment of diseases and disorders responsive to 5-ht (serotonin) re-uptake inhibition |
WO2003102097A1 (en) * | 2002-05-31 | 2003-12-11 | H. Lundbeck A/S | The hydrochloride of (s)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1h-indole |
AU2003243930A1 (en) * | 2002-07-05 | 2004-01-23 | H. Lundbeck A/S | Pharmaceutical composition comprising (s)-(+)-3-(1-(2-(1-acetyl-2,3-dihydro-1h-indol-3-yl)ethyl)-1,2,3,6-tetrahydropyridin-4-yl)-6-chloro-1h-indole |
WO2004020437A1 (en) * | 2002-08-29 | 2004-03-11 | H. Lundbeck A/S | S-(+)-3-{1-[2-(2,3-dihydro-1h-indol-3-yl)ethyl]-3,6-dihydro-2h-pyridin-4-yl}-6-chloro-1h-indole and acid addition salts thereof |
WO2004080407A2 (en) * | 2003-03-07 | 2004-09-23 | Predix Pharmaceuticals Holdings, Inc. | New serotonin modulating compounds and uses therefor |
EA010154B1 (ru) * | 2004-05-11 | 2008-06-30 | Эгиш Дьёдьсердьяр Нирт. | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 |
CN101014576B (zh) * | 2004-09-09 | 2011-05-25 | 默沙东公司 | 芳基螺内酰胺cgrp受体拮抗剂 |
EP1819713B1 (de) * | 2004-11-26 | 2009-09-23 | Janssen Pharmaceutica N.V. | Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität |
TW200800960A (en) * | 2005-08-17 | 2008-01-01 | Lundbeck & Co As H | Novel 2,3-dihydroindole compounds |
US7544685B2 (en) | 2005-08-17 | 2009-06-09 | H. Lundbeck A/S | 2,3-dihydroindole compounds |
WO2007050381A2 (en) * | 2005-10-24 | 2007-05-03 | Janssen Pharmaceutica, N.V. | 3-piperidin-4-yl-indole orl-1 receptor modulators |
WO2008015516A1 (en) * | 2006-07-28 | 2008-02-07 | Pfizer Products Inc. | Fused tricyclic heterocycles for the treatment of schizophrenia |
US8030518B2 (en) * | 2006-11-28 | 2011-10-04 | Valeant Pharmaceuticals International | 1,4 diamino bicyclic retigabine analogues as potassium channel modulators |
PL395469A1 (pl) | 2011-06-29 | 2013-01-07 | Adamed Spólka Z Ograniczona Odpowiedzialnoscia | Pochodne indoloamin do leczenia chorób osrodkowego ukladu nerwowego |
US9963458B2 (en) | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
WO2014102589A1 (en) | 2012-12-27 | 2014-07-03 | Purdue Pharma L.P. | Quinazolin-4(3h)-one-type piperidine compounds and uses thereof |
WO2020081695A1 (en) * | 2018-10-17 | 2020-04-23 | Nikang Therapeutics, Inc. | Indane derivatives as hypoxia inducible factor-2(alpha) inhibitors |
GB201919213D0 (en) * | 2019-12-23 | 2020-02-05 | Ucb Biopharma Sprl | Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2052675T3 (es) * | 1987-11-20 | 1994-07-16 | Hoechst Roussel Pharma | 3-(4-piperazinil-sustituido en 1)butil)-4-tiazolidinonas, un procedimiento para su preparacion y su uso como medicamentos. |
FR2654104B1 (fr) | 1989-11-07 | 1992-01-03 | Adir | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
TW199152B (de) | 1990-11-01 | 1993-02-01 | Takeda Pharm Industry Co Ltd | |
FR2670491B1 (fr) | 1990-12-14 | 1993-02-05 | Adir | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. |
AU6215594A (en) | 1993-03-18 | 1994-10-11 | Merck Sharp & Dohme Limited | Indole derivatives as dopamine d4 antagonists |
GB9305641D0 (en) | 1993-03-18 | 1993-05-05 | Merck Sharp & Dohme | Therapeutic agents |
DE4414113A1 (de) | 1994-04-22 | 1995-10-26 | Merck Patent Gmbh | 3-Indolylpiperidine |
CA2188949A1 (en) | 1994-04-28 | 1995-11-09 | Janusz Jozef Kulagowski | Benzofuran derivatives as d4 receptor antagonists |
ZA954689B (en) * | 1994-06-08 | 1996-01-29 | Lundbeck & Co As H | 4-Aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) piperidines tetrahydropyridines or piperazines |
ZA9711376B (en) | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
EP1089997A1 (de) * | 1998-06-19 | 2001-04-11 | H.Lundbeck A/S | 4,5,6 und 7-indol- und indolin-derivate, ihre herstellung und anwendung |
-
1997
- 1997-12-18 ZA ZA9711376A patent/ZA9711376B/xx unknown
- 1997-12-19 CN CNB971818134A patent/CN1146556C/zh not_active Expired - Fee Related
- 1997-12-19 TR TR1999/01407T patent/TR199901407T2/xx unknown
- 1997-12-19 AT AT97949998T patent/ATE225784T1/de not_active IP Right Cessation
- 1997-12-19 CN CNB031088503A patent/CN1282644C/zh not_active Expired - Fee Related
- 1997-12-19 ES ES97949998T patent/ES2185058T3/es not_active Expired - Lifetime
- 1997-12-19 IL IL13013397A patent/IL130133A/xx not_active IP Right Cessation
- 1997-12-19 SK SK813-99A patent/SK283678B6/sk not_active IP Right Cessation
- 1997-12-19 CZ CZ0222799A patent/CZ297416B6/cs not_active IP Right Cessation
- 1997-12-19 EA EA199900581A patent/EA002158B1/ru not_active IP Right Cessation
- 1997-12-19 DE DE69716296T patent/DE69716296T2/de not_active Expired - Fee Related
- 1997-12-19 PL PL97334011A patent/PL188418B1/pl not_active IP Right Cessation
- 1997-12-19 CN CNB031088511A patent/CN1244558C/zh not_active Expired - Fee Related
- 1997-12-19 AU AU53109/98A patent/AU731243B2/en not_active Ceased
- 1997-12-19 US US09/331,560 patent/US6262087B1/en not_active Expired - Fee Related
- 1997-12-19 NZ NZ335973A patent/NZ335973A/xx unknown
- 1997-12-19 BR BR9714039-2A patent/BR9714039A/pt not_active Application Discontinuation
- 1997-12-19 HU HU0000079A patent/HUP0000079A3/hu unknown
- 1997-12-19 WO PCT/DK1997/000587 patent/WO1998028293A1/en active IP Right Grant
- 1997-12-19 KR KR10-1999-7005622A patent/KR100432297B1/ko not_active IP Right Cessation
- 1997-12-19 EP EP97949998A patent/EP0946542B1/de not_active Expired - Lifetime
- 1997-12-19 UA UA99074138A patent/UA66778C2/uk unknown
- 1997-12-19 JP JP52826298A patent/JP3251300B2/ja not_active Expired - Fee Related
- 1997-12-19 DK DK97949998T patent/DK0946542T3/da active
- 1997-12-19 AR ARP970106065A patent/AR008545A1/es active IP Right Grant
- 1997-12-19 PT PT97949998T patent/PT946542E/pt unknown
-
1999
- 1999-05-28 IS IS5061A patent/IS2018B/is unknown
- 1999-06-14 NO NO19992895A patent/NO318978B1/no not_active IP Right Cessation
- 1999-07-07 BG BG103561A patent/BG63968B1/bg unknown
-
2000
- 2000-08-11 HK HK00105032A patent/HK1025775A1/xx not_active IP Right Cessation
-
2001
- 2001-03-21 US US09/813,480 patent/US6552044B2/en not_active Expired - Fee Related
- 2001-03-21 US US09/814,037 patent/US6352988B2/en not_active Expired - Fee Related
-
2004
- 2004-10-21 NO NO20044514A patent/NO20044514L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69716296D1 (de) | Indan- oder dihydroindolderivate | |
DE69735712D1 (de) | Aryl-pyrimidin-derivate | |
ATE261942T1 (de) | 6-phenylpyridinderivate | |
PT934320E (pt) | Derivados de naftiridina | |
IS4800A (is) | Nýjar 19-nor-pregnene afleiður | |
NO981946D0 (no) | Imidazoquinazolin-derivater | |
IS4419A (is) | Kryddstaukur fyrir krydd | |
ID18010A (id) | Oligosakarida termodifikasi | |
DE69732576D1 (de) | Tetrahydrobenzindolon-derivate | |
BR9709065A (pt) | Derivados de alquilaminobenzotiazole e-benzoxazol | |
IS5026A (is) | 2-metoxýfenýlpíperasín afleiður | |
PT931087E (pt) | Novos derivados de piranosido | |
PT906279E (pt) | Derivados de pirrol | |
DK0923562T3 (da) | Substituerede p-trifluormethylphenyluraciler | |
DE59707428D1 (de) | Substituierte 1-methyl-3-benzyluracile | |
ATE275146T1 (de) | Substituierte pyrazol-3-ylbenzazole | |
BR9711681A (pt) | Novos m-todos | |
BR9706980A (pt) | Derivados de isooxacefem | |
BR9708310A (pt) | Derivados de 2-tioxotetrahidropirimidin-4-ona | |
DE59712222D1 (de) | Substituierte phenyluracile | |
DE59708674D1 (de) | Substituierte 3-phenylpyrazole | |
NO993024D0 (no) | Polysakkarid-peptid-derivater | |
ATA69896A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate | |
ATA73396A (de) | 3-methylimino-3-cephemderivate 3-methylimino-3-cephemderivate | |
BR9704674A (pt) | Derivados de n-benzilazólio |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |